📅 19 September 2022 🕑 10:00AM EDT – 6:00PM EDT
New York City
The Global Fund’s Seventh Replenishment Conference will bring together governments, civil society, and the private sector to take bold action toward the fight against HIV/AIDS, tuberculosis and malaria. The Global Fund’s Seventh Replenishment investment case calls for at least $18 billion from donors to support low- and middle-income countries to get back on track to end HIV/AIDS, TB, and malaria as public health threats by 2030 given the devastating impact of COVID-19.
President Biden will host the Global Fund’s Seventh Replenishment Conference on September 19, 2022, in New York City. The United States is proud to be a founding contributor of, and the largest single donor to, the Global Fund, having contributed nearly $20 billion since 2002.
President Biden’s FY 2023 budget includes a request for $2 billion for the Global Fund intended be a first part of a total U.S. $6 billion three-year Seventh Replenishment pledge, to save lives and continue the fight against HIV/AIDS, tuberculosis, and malaria.
The Global Fund raises funds ahead of each three-year grant cycle at replenishment conferences when donors formally pledge their intended contributions. The Seventh Replenishment Conference will raise funds to be used in the 2023-2025 grant cycle.
A Smart Investment That Saves Lives
A successful Global Fund Replenishment is projected to save 20 million lives between 2024 and 2026 and reduce the mortality rate by 64% across the three diseases by 2026, relative to 2020 levels. It would, through our collective efforts, avert more than 450 million infections between 2024 and 2026, reducing the incidence rate by 58% across the three diseases by 2026, relative to 2020 levels.
Global Fund Replenishment pledges will also catalyze a scale-up of domestic investments of up to $59 billion toward ending the three diseases and strengthening health systems through co-financing requirements and technical assistance on health financing.
A successful Global Fund Replenishment is expected to yield a return on investment of 1:31 – for every $1 invested in fighting the three diseases, there is $31 in health gains and economic returns, further contributing to the achievement of the overall United Nations Sustainable Development Agenda.
